Felix Sahm (A06) is one of the recipients of the German Cancer Prize in the Translational Research Category. The Prize is awarded annually by the German Cancer Society and the German Cancer Foundation and is considered one of the highest distinctions in oncology. Sahm is recognized for his leading contributions to the molecular classification of brain tumors, particularly through the development of integrated diagnostic frameworks that combine DNA methylation profiling, genomic alterations, and computational analysis. These classification systems have substantially improved diagnostic accuracy across tumor entities, refined prognostic stratification, and enabled more biologically informed therapeutic decision‑making.
Felix Sahm’s other scientific awards include the EANO Research Award (2025) and the Paul-Kleihues-Prize (2013).